Cervical cancer screening
Cervical cancer develops slowly and often shows no symptoms until an advanced stage. Organized screening is therefore essential. It detects precancerous changes early, when treatment is simpler and survival rates are higher.
Expanding access to high-quality screening programmes and effective detection systems enables timely diagnosis, better care, and reduces the overall burden of cervical cancer on individuals, health systems, and society.
Contact us →Solutions for cervical screening
PreventUs International supports cervical screening programmes with integrated digital solutions that improve participation, streamline workflows, and ensure secure communication across the entire screening journey.
Smart and automatic selection of target group
Identify eligible women based on age and screening history and send clear invitations automatically.
Smart invitations
Send clear multichannel invitations and reminders to improve participation and follow-up.
Hybrid sampling
Support home sampling or smear tests by General Practitioners. Lab forms are handled automatically.
Lab screening
Samples are analyzed for HPV and results flow directly into the platform for rapid follow-up.
Cytology reports
If HPV is detected, cells are examined for abnormalities and changes are reported clearly.
Secure results
Results reach women quickly and safely through the secure client portal.
Global integrations
The platform integrates with existing laboratory and diagnostic systems worldwide.
Towards better cancer screening in Eastern Europe
Across Eastern Europe, cancer screening programmes are rapidly progressing and are ready for the next step.
Within the EUCanScreen initiative, which aims to ensure high-quality, evidence-based screening for all major cancers and achieve equity across all EU Member States, countries have a major opportunity to further strengthen their existing workflows.
By integrating PreventUs as a modern, data-driven screening platform, national programmes can enhance data quality, improve monitoring, and contribute to the shared European goal of lifting cancer screening performance to a consistently high level across the EU.
Read more →